Veterans’ RightsAn independent resource for veterans
← All decisions
Remanded (sent back)

The Board has remanded the Veteran's claims for prostate cancer and heart disorder, including ischemic heart disease and chest tumors, due to herbicide or other chemical exposure. The appeal is currently under review.

The deciding factor: The Veteran testified that he was exposed to herbicides and DDT during his service in Korea, but there are no records of such exposures. Further investigation into the Veteran's claims is needed.

Claimed conditions
prostate cancer, heart disorder including ischemic heart disease and chest tumors
How they argued it
Not specified
Exposure basis
None
Rating assigned
None in this decision
Decision date
February 11, 2021
Citation
21007964

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 21007964.

What this means for you

A remand sends an issue back for more development, often a new examination or missing records. It does not award the benefit or decide the final outcome. The original decision explains the additional work ordered.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.